Richard J. Busis

Represented Lung Therapeutics, Inc., a clinical-stage biopharmaceutical company developing therapies for life-threatening lung conditions, in its $90 million "sign and close" merger with Aileron Therapeutics, Inc. (Nasdaq: ALRN) and a concurrent $18 million private investment in public equity (PIPE) transaction.

Represented South Jersey Industries, Inc. and its natural gas public utility operating subsidiaries, South Jersey Gas Company and Elizabethtown Gas Company, in connection with a $1 billion master credit facility.

Represented Lung Therapeutics, Inc. as the selling stockholder in the secondary offering of more than one million shares of common stock, valued at $14 million, of TFF Pharmaceuticals, Inc. to affiliates of Hudson Bay Capital Management LP, Corriente Advisors, L.L.C., and Mermelstein Investment Partners L.P., collectively, pursuant to an effective registration statement.

Advised the board of directors of a micro-cap public company in connection with the transition of the chief executive officer.

Represented Utz Quality Foods, LLC in its acquisition of Inventure Foods, Inc. in a deal valued at $165 million. The transaction was completed via a cash tender offer for all outstanding shares of Inventure Foods common stock, followed by a merger of a wholly owned subsidiary of Utz into Inventure Foods pursuant to Section 251(h) of the Delaware General Corporation Law. Inventure Foods will operate as a wholly-owned subsidiary of Utz. Inventure Foods manufactures and sells salted snacks under the brands Boulder Canyon®, TGI Fridays™, Nathan's Famous®, Vidalia Brands®, Poore Brother®, Tato Skins®, and Bob's Texas Style® and has manufacturing facilities in Arizona and Indiana.

Represented Utz Quality Foods, LLC in connection with its acquisition of Alabama-based public snack food company Golden Enterprises, Inc. for $146 million. The acquisition was financed through an investment in Utz by private equity firm Metropoulos & Co. Cozen O'Connor represented Utz in that investment by Metropoulos, which was the largest initial private equity transaction for a U.S. snack food company since 2013.

Represented public company in instituting a commercial paper program.

Represented public companies in negotiating lines of credit with total aggregate amount in excess of $700 million.

Represented public companies in the drafting or reviewing disclosures (Forms 10-K, 10-Q, 8-K; proxy statements, etc.).

Represented public company in multiple issuances of debt securities with an aggregate purchase price of about $500 million.

Represented the joint venture of a public company in the purchase of a steam plant for more than $50 million.

Represented joint venture of a public company in the sale of a heating and cooling facility with a purchase price of approximately $190 million.